These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3145797)

  • 61. MicroCT quantification of in vitro bone resorption of neonatal murine calvaria exposed to IL-1 or PTH.
    Stock SR; Ignatiev KI; Foster SA; Forman LA; Stern PH
    J Struct Biol; 2004 Aug; 147(2):185-99. PubMed ID: 15193647
    [TBL] [Abstract][Full Text] [Related]  

  • 62. One possible solution to the problem of the biochemistry of bone mineral.
    Richelle LJ
    Clin Orthop Relat Res; 1964; 33():211-9. PubMed ID: 5889023
    [No Abstract]   [Full Text] [Related]  

  • 63. Bone changes in rats with adjuvant arthritis: treatment with 1 alpha-hydroxycholecalciferol.
    Binderup L
    Acta Pharmacol Toxicol (Copenh); 1986 Sep; 59(3):228-35. PubMed ID: 3799201
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Yeast-incorporated gallium attenuates glucocorticoid-induced bone loss in rats by inhibition of bone resorption.
    Ren Z; Yang L; Xue F; Meng Q; Wang K; Wu X; Ji C; Jiang T; Liu D; Zhou L; Zhang J; Fu Q
    Biol Trace Elem Res; 2013 Jun; 152(3):396-402. PubMed ID: 23532566
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased bone formation and decreased bone resorption in fetal mouse calvaria as a result of intermittent compressive force in vitro.
    Klein-Nulend J; Veldhuijzen JP; de Jong M; Burger EH
    Bone Miner; 1987 Sep; 2(6):441-8. PubMed ID: 3505768
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effectsof disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP) on mineral and organic components of rat bone.
    Rosenblum IY
    Calcif Tissue Res; 1974; 16(3):239-50. PubMed ID: 4447899
    [No Abstract]   [Full Text] [Related]  

  • 67. Fluoride inhibition of bone mineralization may depend on physical/chemical properties.
    Harrison JE; Hitchman AJ; Hitchman A; Hasany SA
    Bone Miner; 1988 Apr; 4(1):37-47. PubMed ID: 3191271
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of KCA-098, a new benzofuroquinoline derivative, on bone mineral metabolism.
    Kojima M; Tsutsumi N; Nagata H; Itoh F; Ujiie A; Kawashima K; Endo H; Okazaki M
    Biol Pharm Bull; 1994 Apr; 17(4):504-8. PubMed ID: 8069257
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evidence for the promotion of bone mineralization by 1alpha,25-dihydroxycholecalciferol in the rat unrelated to the correction of deficiencies in serum calcium and phosphorus.
    Boris A; Hurley JF; Trmal T; Mallon JP; Matuszewski DS
    J Nutr; 1978 Dec; 108(12):1899-906. PubMed ID: 102741
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gallium nitrate revisited.
    Chitambar CR
    Semin Oncol; 2003 Apr; 30(2 Suppl 5):1-4. PubMed ID: 12776253
    [TBL] [Abstract][Full Text] [Related]  

  • 71. TEI-3313, a novel prostaglandin A1 derivative, prevents bone loss and enhances bone formation in immobilized male rats.
    Ohta T; Azuma Y; Kanatani H; Kiyoki M; Koshihara Y
    J Pharmacol Exp Ther; 1995 Oct; 275(1):450-5. PubMed ID: 7562584
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Small bowel resection in the rat: the effect upon bone and mineral metabolism.
    Kastl S; Gepp H; Sommer T; Kotschenreuther U; Radespiel-Tröger M; Schwille PO; Hohenberger W
    Int J Colorectal Dis; 2002 Mar; 17(2):115-22. PubMed ID: 12014419
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bone disease induced by phenytoin therapy: clinical and experimental study.
    Moro-Alvarez MJ; Díaz Curiel M; de la Piedra C; Mariñoso ML; Carrascal MT
    Eur Neurol; 2009; 62(4):219-30. PubMed ID: 19628941
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interactions of insulin-like growth factor I with dexamethasone on trabecular bone density and mineral metabolism in rats.
    Binz K; Schmid C; Bouillon R; Froesch ER; Jürgensen K; Hunziker EB
    Eur J Endocrinol; 1994 Apr; 130(4):387-93. PubMed ID: 8162170
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats.
    Reitsma PH; Bijvoet OL; Verlinden-Ooms H; van der Wee-Pals LJ
    Calcif Tissue Int; 1980; 32(2):145-57. PubMed ID: 6773632
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of chronic nicotine administration on bone mineral content in mice.
    Broulik PD; Jaráb J
    Horm Metab Res; 1993 Apr; 25(4):219-21. PubMed ID: 8514242
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.
    Lerner UH; Fredholm BB; Ransjö M
    Biochem J; 1986 Dec; 240(2):529-39. PubMed ID: 3028378
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The development of fetal mice long bones in vitro: an assay of bone modeling.
    Soskolne WA; Schwartz Z; Ornoy A
    Bone; 1986; 7(1):41-8. PubMed ID: 3516184
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 1,25-Dihydroxyvitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO).
    Lempert UG; Minne HW; Albrecht B; Scharla SH; Matthes F; Ziegler R
    Bone Miner; 1989 Sep; 7(2):149-58. PubMed ID: 2804450
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.